Literature DB >> 26199377

Protein Kinase C (PKC)ζ Pseudosubstrate Inhibitor Peptide Promiscuously Binds PKC Family Isoforms and Disrupts Conventional PKC Targeting and Translocation.

Amy S Bogard1, Steven J Tavalin2.   

Abstract

PKMζ is generated via an alternative transcriptional start site in the atypical protein kinase C (PKC)ζ isoform, which removes N-terminal regulatory elements, including the inhibitory pseudosubstrate domain, consequently rendering the kinase constitutively active. Persistent PKMζ activity has been proposed as a molecular mechanism for the long-term maintenance of synaptic plasticity underlying some forms of memory. Many studies supporting a role for PKMζ in synaptic plasticity and memory have relied on the PKCζ pseudosubstrate-derived ζ-inhibitory peptide (ZIP). However, recent studies have demonstrated that ZIP-induced impairments to synaptic plasticity and memory occur even in the absence of PKCζ, suggesting that ZIP exerts its actions via additional cellular targets. In this study, we demonstrated that ZIP interacts with conventional and novel PKC, in addition to atypical PKC isoforms. Moreover, when brain abundance of each PKC isoform and affinity for ZIP are taken into account, the signaling capacity of ZIP-responsive pools of conventional and novel PKCs may match or exceed that for atypical PKCs. Pseudosubstrate-derived peptides, like ZIP, are thought to exert their cellular action primarily by inhibiting PKC catalytic activity; however, the ZIP-sensitive catalytic core of PKC is known to participate in the enzyme's subcellular targeting, suggesting an additional mode of ZIP action. Indeed, we have demonstrated that ZIP potently disrupts PKCα interaction with the PKC-targeting protein A-kinase anchoring protein (AKAP) 79 and interferes with ionomycin-induced translocation of conventional PKC to the plasma membrane. Thus, ZIP exhibits broad-spectrum action toward the PKC family of enzymes, and this action may contribute to its unique ability to impair memory.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26199377      PMCID: PMC4576679          DOI: 10.1124/mol.115.099457

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  43 in total

1.  Protein kinase Mzeta is necessary and sufficient for LTP maintenance.

Authors:  Douglas S F Ling; Larry S Benardo; Peter A Serrano; Nancy Blace; Matthew T Kelly; John F Crary; Todd C Sacktor
Journal:  Nat Neurosci       Date:  2002-04       Impact factor: 24.884

2.  Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain.

Authors:  M U Naik; E Benedikz; I Hernandez; J Libien; J Hrabe; M Valsamis; D Dow-Edwards; M Osman; T C Sacktor
Journal:  J Comp Neurol       Date:  2000-10-16       Impact factor: 3.215

3.  Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.

Authors:  Neal M Alto; Scott H Soderling; Naoto Hoshi; Lorene K Langeberg; Rosa Fayos; Patricia A Jennings; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

4.  A role for the beta isoform of protein kinase C in fear conditioning.

Authors:  E J Weeber; C M Atkins; J C Selcher; A W Varga; B Mirnikjoo; R Paylor; M Leitges; J D Sweatt
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.

Authors:  C House; B E Kemp
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

6.  Regulation of GluR1 by the A-kinase anchoring protein 79 (AKAP79) signaling complex shares properties with long-term depression.

Authors:  Steven J Tavalin; Marcie Colledge; Johannes W Hell; Lorene K Langeberg; Richard L Huganir; John D Scott
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Peptides that mimic the pseudosubstrate region of protein kinase C bind to acidic lipids in membranes.

Authors:  M Mosior; S McLaughlin
Journal:  Biophys J       Date:  1991-07       Impact factor: 4.033

8.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  H Nakanishi; K A Brewer; J H Exton
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360.

Authors:  Mark L Dell'Acqua; Kimberly L Dodge; Steven J Tavalin; John D Scott
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

Review 10.  Domain interactions in protein kinase C.

Authors:  C J Pears; P J Parker
Journal:  J Cell Sci       Date:  1991-12       Impact factor: 5.285

View more
  12 in total

1.  The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength.

Authors:  Kelsey Barcomb; Johannes W Hell; Tim A Benke; K Ulrich Bayer
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

2.  Deletion of Protein Kinase C λ in POMC Neurons Predisposes to Diet-Induced Obesity.

Authors:  Mauricio D Dorfman; Jordan E Krull; Jarrad M Scarlett; Stephan J Guyenet; Mini P Sajan; Vincent Damian; Hong T Nguyen; Michael Leitges; Gregory J Morton; Robert V Farese; Michael W Schwartz; Joshua P Thaler
Journal:  Diabetes       Date:  2017-01-10       Impact factor: 9.461

Review 3.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

4.  G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of β-Arrestin.

Authors:  Jiansong Luo; John M Busillo; Ralf Stumm; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2017-03-22       Impact factor: 4.436

5.  Reversing Cocaine-Induced Plasticity with Zeta Inhibitory Peptide.

Authors:  Andre U Deutschmann; Jeffrey D Lenz; Anna G McGrath; Lisa A Briand
Journal:  J Neurosci       Date:  2019-08-13       Impact factor: 6.167

Review 6.  Involvement of PKMζ in Stress Response and Depression.

Authors:  Jianfeng Liu
Journal:  Front Cell Neurosci       Date:  2022-05-20       Impact factor: 6.147

Review 7.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

8.  Epigenetic modification of PKMζ rescues aging-related cognitive impairment.

Authors:  Chen Chen; Shi-Qiu Meng; Yan-Xue Xue; Ying Han; Cheng-Yu Sun; Jia-Hui Deng; Na Chen; Yan-Ping Bao; Fei-Long Zhang; Lin-Lin Cao; Wei-Guo Zhu; Jie Shi; Wei-Hong Song; Lin Lu
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

9.  Actin polymerization controls cilia-mediated signaling.

Authors:  Michael L Drummond; Mischa Li; Eric Tarapore; Tuyen T L Nguyen; Baina J Barouni; Shaun Cruz; Kevin C Tan; Anthony E Oro; Scott X Atwood
Journal:  J Cell Biol       Date:  2018-06-26       Impact factor: 10.539

10.  Scabronine G Methyl Ester Improves Memory-Related Behavior and Enhances Hippocampal Cell Proliferation and Long-Term Potentiation via the BDNF-CREB Pathway in Olfactory Bulbectomized Mice.

Authors:  Osamu Nakagawasai; Jia-Rong Lin; Takayo Odaira; Kohei Takahashi; Wataru Nemoto; Shigeki Moriguchi; Yasushi Yabuki; Yu Kobayakawa; Kohji Fukunaga; Masahisa Nakada; Koichi Tan-No
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.